Search for: "In Interest of Ep"
Results 621 - 640
of 1,023
Sort by Relevance
|
Sort by Date
30 Mar 2017, 10:19 am
Those interested in the effect of Brexit on IP should look out for IPAN's forthcoming report: “IP, Brexit and beyond – a blue-print for action in IP”, which will be based on the event. [read post]
14 Mar 2017, 7:21 am
What will be interesting is the timing of the referendum. [read post]
9 Mar 2017, 4:41 pm
The written judgment in the preliminary proceedings is now available (BPatG 3 LiQ 1/16 (EP)). [read post]
9 Feb 2017, 1:26 am
Briggs and Sales LJ qualified this conclusion (obiter) in that the time value of money may need to be taken into consideration in assessing outstanding benefit and the employee's fair share in the event that the real value of money over time had changed (e.g. as a result of inflation or interest rates). [read post]
25 Jan 2017, 11:25 pm
Indeed, his view is that “...the SPC Regulation aims to balance the interests of patentees with those of other stakeholders. [read post]
27 Dec 2016, 12:00 am
Arrangements under ADA were available to any interested natural or legal person and thus also applied to opponents. [read post]
10 Dec 2016, 3:00 am
The issues found by auditors were raised by DOH employees during the construction of the EPS. [read post]
1 Dec 2016, 4:00 am
However, in the interests of brevity and focus, we shall be looking at the added matter objections in more detail, and summarising the other findings.The ‘349 patent related to an electronic cigarette, one which vaporises a liquid containing nicotine to simulate cigarette smoke. [read post]
14 Nov 2016, 3:36 pm
Indenix is the patentee of EP (UK) 1 523 489 which claims a family of nucleoside analogues for treating hepatitis C and other Flaviviridae infections (a hep C vaccine - "HCV"). [read post]
2 Nov 2016, 4:57 am
The healthcare and life sciences sectors have grown at a rapid pace during recent years. [read post]
11 Oct 2016, 5:13 am
The 31 page judgment is a juicy one, and well worth a read for those interested in this area. [read post]
22 Sep 2016, 7:10 am
"The patent that was found to be obvious in the present case [EP 1 516 628] claims a lyophilised formulation of trastuzumab with three excipients – histidine as a buffer, Tween 20 as a surfactant and trehalose as a lyoprotectant. [read post]
8 Sep 2016, 6:50 am
AbbVie UK had no interest in the subject matter of the application. [read post]
31 Aug 2016, 3:04 am
This decision also contains several interesting statements on substantive law. [read post]
29 Aug 2016, 1:19 pm
This includes: Dizziness Dry Mouth Sexual Dysfunction Increased Appetite & Weight Gain Fever Uncontrollable Movements or Tics Seizures Problems with Breathing or Swallowing Increased risk of death among elderly patients suffering from dementia Risperdal’s long-term injectable form, Risperdal Consta, warns of further effects: High Blood Sugar & Diabetes Painful, Long-Lasting Erections Extrapyramidal Symptoms (EPS), including tardive dyskinesia and dystonia Neuroleptic… [read post]
29 Jul 2016, 1:30 pm
Claim 17 of EP(UK) 0 720 599 (the basic patent) protects a pharmaceutical composition comprising ezetimible and atorvastatin (this was not in dispute). [read post]
22 Jun 2016, 5:18 am
“[N]o matter how important, conspicuous, and controversial the issue, … an administrative agency’s power to regulate in the public interest must always be grounded in a valid grant of authority from Congress. [read post]
9 Jun 2016, 3:07 pm
It is the former argument that is by far the most interesting aspect of this case. [read post]
7 Jun 2016, 11:21 am
A Unitary Patent (UP) differs from the current European Patent (EP) system as it will have unitary effect for all countries of the EU (with the exception of Spain and Croatia). [read post]
1 Jun 2016, 1:44 am
On 12 January 1999, the European Patent Office revoked EP 177. [read post]
